Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-08-05 Shawver Laura Chief Executive Officer Exercise or conversion +78,740 $1.27 $100K 254,242
2022-08-05 Shawver Laura Chief Executive Officer Exercise or conversion · Stock option (right to buy) −78,740 402,997
2022-06-10 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-10 ROOT JONATHAN D Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-10 Powell Andrew Kenneth William Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-10 Koehler Maria Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-10 Islam Saqib Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-10 HERSHBERG ROBERT Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-06-10 CAPPS VICKIE L Director Grant or award · Stock Option (right to buy) +18,000 18,000
2022-05-02 Shawver Laura Chief Executive Officer Grant or award +68,107 175,502
2022-05-02 Shawver Laura Chief Executive Officer Grant or award · Stock Option (right to buy) +136,214 136,214
2022-05-02 Piazza Jonathan Chief Financial Officer Grant or award +43,691 69,225
2022-05-02 Piazza Jonathan Chief Financial Officer Grant or award · Stock Option (right to buy) +87,383 87,383
2022-05-02 Odegard Valerie President and CSO Grant or award +45,233 61,639
2022-05-02 Odegard Valerie President and CSO Grant or award · Stock Option (right to buy) +90,467 90,467
2022-05-02 Hunder Naomi Chief Medical Officer Grant or award +43,177 54,427
2022-05-02 Hunder Naomi Chief Medical Officer Grant or award · Stock Option (right to buy) +86,355 86,355
2022-05-02 Hawkinson Russ Sr. Vice President of Finance Grant or award +28,335 37,251
2022-05-02 Hawkinson Russ Sr. Vice President of Finance Grant or award · Stock Option (right to buy) +56,670 56,670
2022-02-01 Hawkinson Russ Sr. Vice President of Finance Grant or award +7,500 8,954

Page 26 of 31 · 602 trades